Shimizu, Junichi

Datopotamab Deruxtecan in Advanced or Metastatic Non–Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study

Sands, J., Ahn, M.-J., Lisberg, A., Cho, B. C., Blumenschein, G., Shum, E., Pons Tostivint, E., Goto, Y., Yoh, K., Heist, R., et al. (2025) · Journal of Clinical Oncology

Lung Cancer Treatments and MutationsLung Cancer Research Studies

Cited by 130

Trastuzumab Deruxtecan for ERBB2 -Mutant Metastatic Non–Small Cell Lung Cancer With or Without Brain Metastases: A Secondary Analysis of Randomized Clinical Trials

Jänne, P. A., Planchard, D., Goto, K., Smit, E. F., de Langen, A. J., Goto, Y., Ninomiya, K., Kubo, T., Pérol, M., Felip, E., et al. (2025) · JAMA Network Open

Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research

Cited by 27